219 related articles for article (PubMed ID: 30854786)
1. Cancer-testis antigens in canine histiocytic sarcoma and other malignancies.
Nemec PS; Kapatos A; Holmes JC; Stowe DM; Hess PR
Vet Comp Oncol; 2019 Sep; 17(3):317-328. PubMed ID: 30854786
[TBL] [Abstract][Full Text] [Related]
2. Cancer/Testis Antigens: Expression, Regulation, Tumor Invasion, and Use in Immunotherapy of Cancers.
Salmaninejad A; Zamani MR; Pourvahedi M; Golchehre Z; Hosseini Bereshneh A; Rezaei N
Immunol Invest; 2016 Oct; 45(7):619-40. PubMed ID: 27603913
[TBL] [Abstract][Full Text] [Related]
3. Cancer-testis antigens: promising targets for antigen directed antineoplastic immunotherapy.
Bodey B
Expert Opin Biol Ther; 2002 Aug; 2(6):577-84. PubMed ID: 12171503
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic cancer/testis antigens are a hallmarker of cancer and a sensible target for cancer immunotherapy.
Yang P; Meng M; Zhou Q
Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188558. PubMed ID: 33933558
[TBL] [Abstract][Full Text] [Related]
5. The class A macrophage scavenger receptor CD204 is a useful immunohistochemical marker of canine histiocytic sarcoma.
Kato Y; Murakami M; Hoshino Y; Mori T; Maruo K; Hirata A; Nakagawa TL; Yanai T; Sakai H
J Comp Pathol; 2013 Feb; 148(2-3):188-96. PubMed ID: 22901707
[TBL] [Abstract][Full Text] [Related]
6. The potential immune-eliciting cancer testis antigens in colorectal cancer.
Chi Soh JE; Abu N; Jamal R
Immunotherapy; 2018 Sep; 10(12):1093-1104. PubMed ID: 30185136
[TBL] [Abstract][Full Text] [Related]
7. The canine MHC class Ia allele DLA-88*508:01 presents diverse self- and canine distemper virus-origin peptides of varying length that have a conserved binding motif.
Ross P; Nemec PS; Kapatos A; Miller KR; Holmes JC; Suter SE; Buntzman AS; Soderblom EJ; Collins EJ; Hess PR
Vet Immunol Immunopathol; 2018 Mar; 197():76-86. PubMed ID: 29475511
[TBL] [Abstract][Full Text] [Related]
8. Cancer testis antigens in sarcoma: Expression, function and immunotherapeutic application.
Wei R; Dean DC; Thanindratarn P; Hornicek FJ; Guo W; Duan Z
Cancer Lett; 2020 Jun; 479():54-60. PubMed ID: 31634526
[TBL] [Abstract][Full Text] [Related]
9. Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.
Gordeeva O
Semin Cancer Biol; 2018 Dec; 53():75-89. PubMed ID: 30171980
[TBL] [Abstract][Full Text] [Related]
10. Cancer/testis antigens trigger epithelial-mesenchymal transition and genesis of cancer stem-like cells.
Yang P; Huo Z; Liao H; Zhou Q
Curr Pharm Des; 2015; 21(10):1292-300. PubMed ID: 25506890
[TBL] [Abstract][Full Text] [Related]
11. Expression of Cancer-Testis Antigens in Pediatric Cancers.
Ghafouri-Fard S
Asian Pac J Cancer Prev; 2015; 16(13):5149-52. PubMed ID: 26225644
[TBL] [Abstract][Full Text] [Related]
12. Molecular cytogenetic characterization of canine histiocytic sarcoma: A spontaneous model for human histiocytic cancer identifies deletion of tumor suppressor genes and highlights influence of genetic background on tumor behavior.
Hedan B; Thomas R; Motsinger-Reif A; Abadie J; Andre C; Cullen J; Breen M
BMC Cancer; 2011 May; 11():201. PubMed ID: 21615919
[TBL] [Abstract][Full Text] [Related]
13. Cancer/Testis Antigens as Targets for RNA-Based Anticancer Therapy.
Shim K; Jo H; Jeoung D
Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834126
[TBL] [Abstract][Full Text] [Related]
14. Methylation Profile of Cancer Testis Antigens in Colorectal Cancer.
Abu N; Rus Bakarurraini NAA; Nasir SN; Ishak M; Baharuddin R; Jamal R; Ab Mutalib NS
Iran J Immunol; 2023 Mar; 20(1):83-91. PubMed ID: 36932973
[TBL] [Abstract][Full Text] [Related]
15. Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy.
Shraibman B; Kadosh DM; Barnea E; Admon A
Mol Cell Proteomics; 2016 Sep; 15(9):3058-70. PubMed ID: 27412690
[TBL] [Abstract][Full Text] [Related]
16. Cancer/testis antigens: from serology to mRNA cancer vaccine.
Fan C; Qu H; Wang X; Sobhani N; Wang L; Liu S; Xiong W; Zeng Z; Li Y
Semin Cancer Biol; 2021 Nov; 76():218-231. PubMed ID: 33910064
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of calretinin in canine testicular tumours and normal canine testicular tissue.
Radi ZA; Miller DL
Res Vet Sci; 2005 Oct; 79(2):125-9. PubMed ID: 15924929
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.
Asada H; Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2015 Jun; 77(6):677-84. PubMed ID: 25715778
[TBL] [Abstract][Full Text] [Related]
19. Quantitative PCR and immunohistochemical analyses of HMGB1 and RAGE expression in canine disseminated histiocytic sarcoma (malignant histiocytosis).
Sterenczak KA; Kleinschmidt S; Wefstaedt P; Eberle N; Hewicker-Trautwein M; Bullerdiek J; Nolte I; Murua Escobar H
Anticancer Res; 2011 May; 31(5):1541-8. PubMed ID: 21617208
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of mRNA expression of surface antigens between histiocytic and nonhistiocytic sarcoma in dogs.
Yamazaki H; Takagi S; Oh N; Hoshino Y; Hosoya K; Okumura M
J Vet Intern Med; 2014; 28(1):204-10. PubMed ID: 24428323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
